Shruti Jolly
Overview
Explore the profile of Shruti Jolly including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
131
Citations
2526
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Allen S, Schonewolf C, Schipper M, Yin H, Paximadis P, Kestin L, et al.
Int J Radiat Oncol Biol Phys
. 2025 Mar;
PMID: 40074046
Purpose/objective(s): Use of intensity-modulated radiation therapy (IMRT) versus three-dimensional conformal external beam radiation therapy (3D-CRT) for definitive chemoradiation therapy (CRT) in locally advanced non-small cell lung cancer (LA-NSCLC) has been...
2.
Paradis K, Mayo C, Matrosic C, Prisciandaro J, Rosen B, Allen S, et al.
Int J Radiat Oncol Biol Phys
. 2025 Mar;
PMID: 40068779
Introduction: Reirradiation (reRT) has become increasingly prevalent due to an aging population and advancements in cancer detection and treatment. However, the field is still lacking standardized dosimetric evaluation methods and...
3.
Kong F, Hu C, Pryma D, Duan F, Matuszak M, Xiao Y, et al.
J Clin Oncol
. 2024 Oct;
42(33):3935-3946.
PMID: 39365957
Purpose: NRG-RTOG0617 demonstrated a detrimental effect of uniform high-dose radiation in stage III non-small cell lung cancer. NRG-RTOG1106/ECOG-ACRIN6697 (ClinicalTrials.gov identifier: NCT01507428), a randomized phase II trial, studied whether midtreatment F-fluorodeoxyglucose...
4.
Yu H, Lam K, Green M, Wu H, Yang L, Wang W, et al.
J Natl Cancer Cent
. 2024 Jul;
1(2):31-38.
PMID: 39035770
Purpose: This study aimed to examine the effect of radiation esophagitis (RE) and the dynamics of RE on subsequent survival in non-small cell lung cancer (NSCLC) patients who underwent radiotherapy....
5.
Edwards D, Schonewolf C, Rice J, Schipper M, Ten Haken R, Matuszak M, et al.
Int J Radiat Oncol Biol Phys
. 2024 Jul;
120(5):1332-1343.
PMID: 38971385
Purpose: Local failure rates after treatment for locally advanced non-small cell lung cancer (NSCLC) remain high. Efforts to improve local control with a uniform dose escalation or dose escalation to...
6.
Herr D, Yin H, Bergsma D, Dragovic A, Matuszak M, Grubb M, et al.
Radiother Oncol
. 2024 May;
197:110349.
PMID: 38815695
Introduction: Limiting acute esophagitis remains a clinical challenge during the treatment of locally advanced non-small cell lung cancer (NSCLC). Methods: Demographic, dosimetric, and acute toxicity data were prospectively collected for...
7.
Ramanathan S, Hochstedler K, Laucis A, Movsas B, Stevens C, Kestin L, et al.
Clin Lung Cancer
. 2024 Jan;
25(4):e201-e209.
PMID: 38290875
Introduction: Treatment for inoperable stage II to III non-small cell lung cancer (NSCLC) involves chemo-radiotherapy (CRT). However, some patients transition to hospice or die early during their treatment course. We...
8.
Purcell E, Niu Z, Owen S, Grzesik M, Radomski A, Kaehr A, et al.
Cell Rep
. 2024 Jan;
43(2):113687.
PMID: 38261515
Circulating tumor cells (CTCs) are early signs of metastasis and can be used to monitor disease progression well before radiological detection by imaging. Using an ultrasensitive graphene oxide microfluidic chip...
9.
Ohri N, Jolly S, Cooper B, Kabarriti R, Bodner W, Klein J, et al.
J Clin Oncol
. 2023 Nov;
42(5):562-570.
PMID: 37988638
Purpose: Standard therapy for locally advanced non-small-cell lung cancer (LA-NSCLC) is concurrent chemoradiotherapy followed by adjuvant durvalumab. For biomarker-selected patients with LA-NSCLC, we hypothesized that sequential pembrolizumab and risk-adapted radiotherapy,...
10.
Sun Y, Salerno S, He X, Pan Z, Yang E, Sujimongkol C, et al.
Sci Rep
. 2023 May;
13(1):7318.
PMID: 37147440
As portable chest X-rays are an efficient means of triaging emergent cases, their use has raised the question as to whether imaging carries additional prognostic utility for survival among patients...